Dermatologic Therapy
Overview
Dermatologic Therapy is a peer-reviewed journal dedicated to the latest advancements in the field of dermatology. It provides a platform for dermatologists, researchers, and clinicians to share their expertise and insights on various dermatologic conditions, treatment modalities, and therapeutic approaches. With a focus on evidence-based practices, this journal offers comprehensive reviews, original research articles, and clinical studies, making it an essential resource for professionals seeking to enhance patient care and stay updated on the latest developments in dermatologic therapy.
Details
Details
Abbr.
Dermatol Ther
Start
1996
End
Continuing
Frequency
Six no. a year, 2004-
p-ISSN
1396-0296
e-ISSN
1529-8019
Country
United States
Language
English
Specialty
Dermatology
Metrics
Metrics
h-index / Ranks: 4204
82
SJR / Ranks: 5494
778
CiteScore / Ranks: 5521
4.70
JIF / Ranks: 2654
3.6
Recent Articles
1.
Mandel J, Mehta J, Hafer R, Ayub M, Nusrat F, Yang H, et al.
Dermatol Ther
. 2024 Dec;
2024.
PMID: 39668908
There have been several reports of dupilumab use and the development of CTCL; however, the risk of CTCL development has not been adequately evaluated at the population level. The objective...
2.
3.
Nakamura K, Sato E, Imafuku S
Dermatol Ther
. 2022 Nov;
35(12):e15963.
PMID: 36366826
No abstract available.
4.
Li Y, Zhang M, Zhou H, Zhao K, Yuan X, Liu Y, et al.
Dermatol Ther
. 2022 Nov;
35(12):e15973.
PMID: 36354266
No abstract available.
5.
Nofal A, Fawzy M, Eldeeb F, Nofal H, El-Hawary E
Dermatol Ther
. 2022 Nov;
35(12):e15964.
PMID: 36346210
Although oral isotretinoin has been considered as a potential therapeutic option for the treatment of different types of warts, the optimum dosage regimen is not yet well-established. To evaluate the...
6.
Kassem B, Ismail M, Hassan F
Dermatol Ther
. 2022 Nov;
35(12):e15974.
PMID: 36346039
Protocols for treating acne with isotretinoin have varied widely because some factors associated with relapse and treatment duration have not yet been fully determined. This paper evaluates the effectiveness of...
7.
Balestri R, Rech G, Girardelli C, Magnano M
Dermatol Ther
. 2022 Nov;
35(12):e15971.
PMID: 36346033
No abstract available.
8.
Shaker E, Allam S, Mabrouk M, Elgharbawy N, Salaam S
Dermatol Ther
. 2022 Nov;
35(12):e15969.
PMID: 36346030
There is a paucity of data about the impact of systemic statins on vitiliginous lesions in non-segmental vitiligo (NSV) patients. To the best of our knowledge, no other studies have...
9.
Sagduyu I, Marakli O, Oraloglu G, Bulut Okut E, Unal I
Dermatol Ther
. 2022 Nov;
35(12):e15970.
PMID: 36346028
Melasma is an acquired hyperpigmentation disease characterized by hyperpigmented patches in sun-exposed areas that significantly impairs life quality. Topical treatments such as hydroquinone, retinoic acid, azelaic acid, chemical peels and...
10.